The session schedule for this year’s PH Professional Network (PHPN) Symposium, “Influencing the Practice: The Art and Science of Treating Pulmonary Hypertension,” being held from Sept. 5-7 in Washington, D.C., has an exceptional lineup of more than 50 respected pulmonary hypertension (PH) experts.
Among the highlights of this year’s Symposium is an expert panel discussion on therapy transitions, which is an area of growing interest in the PH field.
This session will discuss the increasingly common practice of transitioning between PAH therapies and the several reasons for doing so, including fewer adverse effects, greater benefit and greater convenience.
Murali Chakinala, M.D., FCCP, will moderate the roundtable-style discussion, and discussants will include: Charles D. Burger, M.D., FCCP, ATSF; Jeffrey Fineman, M.D.; Jessica Humphrey, PharmD, BCPS; Juliana Liu, R.N., M.S.N., ANP-C; Susie McDevitt, M.S.N., ACNP-BC and Tim Williamson, M.D., FCCP.
This therapy transitions session is just one of the many that attendees can participate in with their more than 400 peers at Symposium. This year also includes a track on the latest in treatment and research in the pediatric PH field and many sessions for newcomers to the PH-treating field.
Attendees can earn up to 12.5 hours of CME/CEU.
Information about the 2019 Symposium can be found at PHAssociation.org/Symposium/Registration.